A detailed history of Newbridge Financial Services Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 1,778 shares of MRNA stock, worth $97,149. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,778
Previous 1,710 3.98%
Holding current value
$97,149
Previous $182,000 15.93%
% of portfolio
0.08%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 11, 2024

BUY
$101.21 - $166.61 $6,882 - $11,329
68 Added 3.98%
1,778 $211,000
Q1 2024

Apr 24, 2024

SELL
$85.37 - $115.44 $9,902 - $13,391
-116 Reduced 6.35%
1,710 $182,000
Q4 2023

Mar 28, 2024

BUY
$69.51 - $104.43 $3,475 - $5,221
50 Added 2.82%
1,826 $181,000
Q3 2023

Oct 17, 2023

BUY
$96.41 - $126.61 $11,569 - $15,193
120 Added 7.25%
1,776 $183,000
Q2 2023

Jul 21, 2023

SELL
$118.5 - $160.53 $6,873 - $9,310
-58 Reduced 3.38%
1,656 $201,000
Q4 2022

Jan 17, 2023

BUY
$118.38 - $210.04 $18,585 - $32,976
157 Added 10.08%
1,714 $0
Q3 2022

Oct 13, 2022

BUY
$118.07 - $194.18 $10,862 - $17,864
92 Added 6.28%
1,557 $184,000
Q2 2022

Jul 15, 2022

BUY
$117.13 - $176.59 $23,426 - $35,318
200 Added 15.81%
1,465 $209,000
Q1 2022

Apr 26, 2022

BUY
$126.46 - $235.05 $23,142 - $43,014
183 Added 16.91%
1,265 $218,000
Q4 2021

Jan 19, 2022

BUY
$225.82 - $368.51 $14,452 - $23,584
64 Added 6.29%
1,082 $275,000
Q3 2021

Oct 27, 2021

BUY
$221.9 - $484.47 $126,926 - $277,116
572 Added 128.25%
1,018 $392,000
Q2 2021

Sep 07, 2021

SELL
$129.91 - $234.98 $32,477 - $58,745
-250 Reduced 35.92%
446 $105,000
Q1 2021

Sep 07, 2021

BUY
$109.18 - $185.98 $15,394 - $26,223
141 Added 25.41%
696 $91,000
Q4 2020

Sep 07, 2021

SELL
$65.74 - $169.86 $29,517 - $76,267
-449 Reduced 44.72%
555 $58,000
Q3 2020

Sep 07, 2021

BUY
$54.34 - $94.85 $54,557 - $95,229
1,004 New
1,004 $71,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.